Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
1.040
-0.180 (-14.75%)
At close: Feb 27, 2026, 4:00 PM EST
1.020
-0.020 (-1.96%)
After-hours: Feb 27, 2026, 7:58 PM EST
Company Description
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.
It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.
Profusa, Inc. is based in Berkeley, California.
Profusa, Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Ben Hwang |
Contact Details
Address: 626 Bancroft Way, Suite A Berkeley, California 94710 United States | |
| Phone | 925 997 6925 |
| Website | profusa.com |
Stock Details
| Ticker Symbol | PFSA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001859807 |
| CUSIP Number | 74319X207 |
| ISIN Number | US74319X2071 |
| Employer ID | 86-3437271 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ben Chung-Bin Hwang Ph.D. | Chief Executive Officer and Chairman |
| William McMillan | Co-founder, Chief Scientific Officer and Head of Research |
| David Icke | Head of Digital Health Business |
| Sean Givens | Head of Government Business |
| Phil Constantinou | Head of Software and Data Science |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 17, 2026 | EFFECT | Notice of Effectiveness |
| Feb 17, 2026 | EFFECT | Notice of Effectiveness |
| Feb 17, 2026 | 424B3 | Prospectus |
| Feb 17, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 13, 2026 | 8-K | Current Report |
| Feb 13, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 13, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 10, 2026 | 424B3 | Prospectus |
| Feb 10, 2026 | 424B3 | Prospectus |
| Feb 10, 2026 | 424B3 | Prospectus |